Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Non-squamous Non-small Cell Lung Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Breast Neoplasms 2 Lung Neoplasms 1 Liver Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 ESCC 1 Desmoid Tumors 1 Advanced Solid Tumor 1

Interventions

Radiosurgery 7 lenvatinib 5 Radiofrequency Ablation 5 Electroporation 5 Radiotherapy 3 Patient Navigation 3 Laparoscopy 3 Hepatectomy 3 Exercise 3 sintilimab 2 perflutren 2 Surgical Procedures, Operative 2 Standard of Care 2 Proton Therapy 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Bupivacaine 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × anlotinib × Clear all

NCT03766776 2018-12-11

ATAHC

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡